Randomized Trialhigh evidence

Mitigating End-Stage Fatigue: Acute Inhaled Salmeterol Preserves Sprint Power in Simulated Cycling.

Scandinavian journal of medicine & science in sports·November 1, 2025·PMID 41195895

Why it matters

In competitive road cycling, final sprints often determine race outcomes, and any ergogenic effect of a permitted therapeutic agent could influence performance and fairness. This study challenges the assumption that inhaled salmeterol at therapeutic doses has no performance-enhancing effect, raising questions for anti-doping policy and athlete management.

Infographic summary of Mitigating End-Stage Fatigue: Acute Inhaled Salmeterol Preserves Sprint Power in Simulated Cycling.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled